Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000701090 | SCV000829873 | benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2024-07-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004965694 | SCV005536082 | likely benign | Inborn genetic diseases | 2024-11-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000701090 | SCV002087283 | uncertain significance | Alpha thalassemia-X-linked intellectual disability syndrome | 2021-02-03 | no assertion criteria provided | clinical testing |